Efficacy of Isolated Masseter Versus Masseter- Sternocleidomastoid Trigger Points Injection by Magnesium Sulfate for Myofacial Pain
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 30
- 主要终点
- muscle pain
研究概览
简要总结
The patients will be randomly assigned to one of the two groups according to the treatment method: group I (masseter group) and group II (masseter &sternocleidomastoid group) where each patient will be injected 0.5ml in each trigger point (TrPs) of magnesium sulphate according to the treatment group by the same operator. The treatment method for TrPs will be the primary predictor variable. Patients will be examined at the following intervals: during diagnosis, 1-month, 3-months, and 6-months post-injection. The participated patients will be assessed using pain score measured on a 10-point visual analogue scale (VAS), the 0 indicating no pain and 10 indicating the worst pain ever
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •definite diagnosis of myofascial pain
- •presence of one or more unilateral or bilateral trigger points in the masseter muscle and sternocleidomastoid muscle;
- •no history of any invasive procedures of the related masseter muscle.
排除标准
- •any painful conditions (other than myofascial trigger points) affecting the orofacial region
- •any systemic diseases that could masticatory function (e.g., rheumatoid arthritis and epilepsy);
- •pregnancy and lactation
研究组 & 干预措施
masseter muscle
干预措施: masseter muscle (Drug)
masseter and sternocleidomastoid muscles
干预措施: masseter and sternocleidomastoid muscle (Drug)
结局指标
主要结局
muscle pain
时间窗: 6 months
by visual analogue scal
次要结局
未报告次要终点
研究者
Shaimaa Mohsen
associate professor
Fayoum University